Merit Medical Systems, Inc.
NASDAQ:MMSIMedical - Instruments & Supplies
+$1.16 today
- Market cap
- $5.15B
- Beta
- 0.53
- P/E (TTM)
- 28.4
- EPS (TTM)
- $2.34
Volume 0.46M
Average 0.79M
MMSI Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Merit Medical Systems, Inc.NASDAQ: MMSI
Stock-Based Compensation · Q3 FY2026 · quarter ended Sep 2026
Stock-based compensation grows, but more slowly than its trailing trend
Q3 FY2026 stock-based compensation of $13.62M rose 0.1% year over year, behind the +5.4% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 5.5% from the prior quarter. Over 3 fiscal years it compounded at +34.1% a year.
Context
- Stock-based compensation amounted to 2.9% of revenue in FY2025, up 0.8 pp from a year earlier.
- Stock-based compensation increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +0.1% toward the trailing-twelve-month pace of +5.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 43.46M USD
- Year-over-year change
- +52.6%
- 4-year CAGR
- +28.2%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 43.46M | +52.6% |
| FY2024 | 2024-12-31 | 28.47M | +33.5% |
| FY2023 | 2023-12-31 | 21.33M | +18.2% |
| FY2022 | 2022-12-31 | 18.04M | +12.1% |
| FY2021 | 2021-12-31 | 16.09M | — |
Stock-Based Compensation vs competitors
How MMSI compares with its peers on the latest reported figures
- MMSI's LTM Sep 2026 stock-based compensation of $45.39M is the 5th largest of the 10 companies compared; the peer median is $41.12M.
- Its year-over-year change of +5.4% is the 6th highest of 10, against a peer median of +5.7%.
- Stock-based compensation amounts to 2.8% of revenue for MMSI, versus a peer median of 1.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $204M | +270.9% | — | 1.0% | |
| LTM Jun 2026 | $167M | +23.7% | +63.3% | 2.0% | |
| LTM Jun 2026 | $166M | +5.7% | +10.8% | 0.8% | |
| LTM Jun 2026 | $47.27M | +13.2% | +15.8% | 8.3% | |
| LTM Sep 2026 | $45.39M | +5.4% | +34.1% | 2.8% | |
| LTM Jun 2026 | $41.12M | -19.2% | +15.7% | 1.9% | |
| LTM Jun 2026 | $20.21M | -33.5% | — | 0.8% | |
| LTM Mar 2026 | $19.96M | -39.8% | +9.2% | 1.5% | |
| LTM Feb 2026 | $11.69M | +16.5% | -3.0% | 3.7% | |
| LTM Mar 2026 | $5.78M | -17.5% | +23.3% | 2.3% | |
| Peer median (excluding MMSI) | $41.12M | +5.7% | +15.7% | 1.9% | |
Competitors are the stored peer set for MMSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 48.45M | 74.52M | 94.41M | 120.36M | 128.49M |
| Depreciation & Amortization | 95.78M | 92.2M | 101.29M | 114.73M | 134.65M |
| Deferred Income Tax | (4.63M) | (14.92M) | (12.64M) | (14.87M) | 5.21M |
| Stock-Based Compensation | 16.09M | 18.04M | 21.33M | 28.47M | 43.46M |
| Change in Working Capital | (17.84M) | (71.4M) | (70.02M) | (36.95M) | (23.34M) |
| Accounts Receivables | (8.62M) | (15.12M) | (9.55M) | (21.7M) | (2.73M) |
| Inventory | (25.18M) | (47.93M) | (32.11M) | (2.29M) | (21.6M) |
| Accounts Payables | 6.05M | 12.66M | (7.3M) | (2.31M) | 1.01M |
| Other Working Capital | 9.91M | (21.01M) | (21.08M) | (10.64M) | (26K) |
| Other Non-Cash Items | 9.37M | 15.86M | 10.78M | 9.06M | 8.9M |
| Operating Cash Flow | 147.23M | 114.29M | 145.15M | 220.8M | 297.37M |
| Capital Expenditures | (27.94M) | (45.03M) | (36.7M) | (38.04M) | (84.84M) |
| Acquisitions (Net) | (7.17M) | (8.29M) | (137.85M) | (320.18M) | (144.77M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (2.05M) | (4.08M) | (799K) | (10.43M) | (17.78M) |
| Investing Cash Flow | (37.16M) | (57.4M) | (175.35M) | (368.65M) | (247.39M) |
| Debt Repayment | (108.5M) | (44.94M) | 619.58M | (99.06M) | 0 |
| Common Stock Issued | 21.31M | 20.07M | 15.58M | 40.91M | 28.21M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (11.24M) | (35.39M) | (75.9M) | (1.85M) | (12.21M) |
| Financing Cash Flow | (98.44M) | (60.26M) | 559.27M | (60.01M) | 16M |
| Effect of Forex Changes | (801K) | (3.83M) | (484K) | (2.52M) | 3.8M |
| Net Change in Cash | 10.83M | (7.19M) | 528.59M | (210.38M) | 69.78M |
| Free Cash Flow | 119.29M | 69.26M | 108.45M | 182.76M | 212.54M |
Merit Medical Systems, Inc.
NASDAQ:MMSI
Intrinsic Alpha fair value
Locked
Current Price
$85.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.